Healthcare -
Biotechnology - NASDAQ - US
$ 25.33
11 %
$ 33.6 M
Market Cap
-0.38
P/E
LYRA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities LYRA - Lyra Therapeutics, Inc.
80.3 M
LAST VALUE
79.87%
2 YEAR CAGR
228.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR